Jump to Navigation
Trends and Sentiments
Comments and Analysis
Volatility, Confusion Reign As PBoC Intervenes: Chinese...
Shanghai stocks leap 7.82% at open on government boosts
Iran nuclear talks 'could go either way' in...
Vyapam: Is BJP not backing Shivraj? | Two more scams in...
Craig Stephen's This Week in China: Why Beijing...
Huawei's Sun Yafang Repeats Atop New Forbes China...
Divergent housing market performance in large, smaller...
Hillary Clinton accuses China of widespread hacking
A 'No' vote means probability of a Grexit would...
Technology Leads Week With 5 IPO filings; 5 More Added To Calendar
8 U.S. IPOs Planned For The Week
IPO Preview: Cempra Holdings
2 Life Sciences IPOs Debut Below Target
Caesars Stands Out In A Busy IPO Week With Strong Returns
Trius Therapeutics: The Calm Before The Storm
2012 Biotech IPOs: Age Of The Dreamers?
2 Promising Biopharma Companies To Examine
Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
Companies That Can Mend The Biotech Market: Stephen Brozak
Cempra's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Cempra Management Discusses Toyama Exclusive Agreement Conference (Transcript)
Cempra's CEO Presents at BARDA Contract Award Conference (Transcript)
Can Cempra Beat The Superbugs?
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Cempra's CEO Discusses Q3 2013 Results - Earnings Call Transcript
This Antibiotic Play May Be The Trius Of 2014
Cempra Holdings Hosts Solithromycin and Taksta Clinical Update Conference Call (Transcript)
Do Away With The Pill-A-Day Biotech Model: Steve Brozak
Cempra: Safety Results Solidifying Market Position
Cempra's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Promising Biotechs Target New Ways To Kill Bad Bugs: Venture Capitalist Dennis Purcell
Cempra's CEO Discusses Q1 2014 Results - Earnings Call Transcript
Suicide bombers force soul-searching in British...
Thousands greet pope at start of South American...
EUR/GBP: 1.4091 USD/EUR: 1.1041 JPY/USD: 122.5375
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions